During the last session, Mainz Biomed N.V (NASDAQ:MYNZ)’s traded shares were 0.45 million, with the beta value of the company hitting 0.33. At the end of the trading day, the stock’s price was $6.04, reflecting an intraday loss of -7.50% or -$0.49. The 52-week high for the MYNZ share is $45.60, that puts it down -654.97 from that peak though still a striking 39.57% gain since the share price plummeted to a 52-week low of $3.65. The company’s market capitalization is $13.42M, and the average intraday trading volume over the past 10 days was 0.5 million shares, and the average trade volume was 189.77K shares over the past three months.

Mainz Biomed N.V (NASDAQ:MYNZ) trade information

Mainz Biomed N.V (MYNZ) registered a -7.50% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -7.50% in intraday trading to $6.04, hitting a weekly high. The stock’s 5-day price performance is -18.49%, and it has moved by 20.80% in 30 days. Based on these gigs, the overall price performance for the year is -84.90%. The short interest in Mainz Biomed N.V (NASDAQ:MYNZ) is 35008.0 shares and it means that shorts have 0.3 day(s) to cover.

Mainz Biomed N.V (MYNZ) estimates and forecasts

In the rating firms’ projections, revenue will increase 18.54% compared to the previous financial year.

While earnings are projected to return 63.58% in 2025.

MYNZ Dividends

Mainz Biomed N.V is due to release its next quarterly earnings in March. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.

The next largest institutional holding, with 25000.0 shares, is of VONTOBEL HOLDING LTD.’s that is approximately 0.1181% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $10025.0.

Data provided on Nov 30, 2024 indicates that Fidelity NASDAQ Composite Index Fund owns about 9.01 shares. This amounts to just over 0.45 percent of the company’s overall shares, with a $54432.0 market value.